Credit Suisse AG Has $3.03 Million Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Credit Suisse AG raised its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 3.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,265 shares of the company’s stock after buying an additional 2,633 shares during the quarter. Credit Suisse AG’s holdings in Ryan Specialty were worth $3,029,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in RYAN. Morgan Stanley grew its holdings in Ryan Specialty by 515.7% in the 4th quarter. Morgan Stanley now owns 2,467,647 shares of the company’s stock valued at $102,432,000 after buying an additional 2,066,855 shares in the last quarter. Vanguard Group Inc. grew its holdings in Ryan Specialty by 42.3% in the 1st quarter. Vanguard Group Inc. now owns 6,747,855 shares of the company’s stock valued at $261,749,000 after buying an additional 2,006,018 shares in the last quarter. State Street Corp grew its holdings in shares of Ryan Specialty by 173.6% during the 2nd quarter. State Street Corp now owns 1,216,310 shares of the company’s stock worth $47,667,000 after purchasing an additional 771,733 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Ryan Specialty by 35.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,072,078 shares of the company’s stock worth $81,205,000 after purchasing an additional 539,003 shares during the period. Finally, First Trust Advisors LP increased its position in shares of Ryan Specialty by 309.8% in the fourth quarter. First Trust Advisors LP now owns 565,239 shares of the company’s stock worth $23,463,000 after purchasing an additional 427,321 shares during the period. 34.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, insider Brendan Martin Mulshine sold 35,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 6th. The shares were sold at an average price of $41.71, for a total value of $1,459,850.00. Following the completion of the transaction, the insider now directly owns 39,592 shares in the company, valued at approximately $1,651,382.32. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Nicholas Dominic Cortezi sold 25,000 shares of the stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $44.01, for a total transaction of $1,100,250.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Brendan Martin Mulshine sold 35,000 shares of the firm’s stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $41.71, for a total transaction of $1,459,850.00. Following the completion of the transaction, the insider now directly owns 39,592 shares in the company, valued at $1,651,382.32. The disclosure for this sale can be found here. In the last ninety days, insiders sold 603,132 shares of company stock worth $26,746,975. 54.51% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company raised their price target on Ryan Specialty from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 4th. Barclays raised their price target on Ryan Specialty from $51.00 to $52.00 and gave the stock an “overweight” rating in a research report on Friday, August 4th. Finally, JPMorgan Chase & Co. raised their price target on Ryan Specialty from $39.00 to $43.00 in a research report on Thursday, July 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, Ryan Specialty has a consensus rating of “Hold” and an average price target of $48.29.

Ryan Specialty Price Performance

RYAN stock opened at $48.98 on Friday. The company has a 50 day simple moving average of $45.06 and a 200 day simple moving average of $42.58. The stock has a market cap of $12.75 billion, a price-to-earnings ratio of 81.63 and a beta of 0.45. Ryan Specialty Holdings, Inc. has a 1 year low of $32.13 and a 1 year high of $49.39. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.22 and a quick ratio of 1.22.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, August 3rd. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The business had revenue of $585.10 million during the quarter, compared to analysts’ expectations of $575.80 million. Ryan Specialty had a net margin of 10.34% and a return on equity of 39.86%. The firm’s quarterly revenue was up 19.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.39 EPS. Research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.38 EPS for the current fiscal year.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.